We have manufacturers, suppliers and service providers from the area Autotransfusion systems

The autotransfusion system is an electronic device that administers blood into a patient. It works in a similar way as a human transfusion. The patient is connected to a chest drainage system, which carries the blood to the collection bag. When the collection bag is full, the patient is disconnected and a new bag is connected. The process is repeated until no more blood is required. The collection canister is filled and replaced. A coagulant is then added to the blood to make the procedure safe and effective.

The global market for autotransfusion products includes postoperative systems and intraoperative systems. The benefits of using an autotransfusion system are that it is safer, has more compatible blood for patients, and reduces the risk of transmission of blood-borne diseases. The disadvantages of using allogeneic transfusion include hemolytic reactions, transfusion of infectious diseases, and immunosuppressive reactions. As a result, autotransfusion devices have become increasingly popular.

The North American region is expected to dominate the overall market for autotransfusion systems in the near future. The region is expected to grow due to its high number of surgeries and well-developed healthcare infrastructure. In addition, the government is focusing on raising awareness about the need for auto-transfusion. The United States has the largest share of the North American market, with its developed healthcare infrastructure and supportive healthcare policies. This is a critical area for the industry.

The autotransfusion systems market is moderately competitive. The report identifies several major players. Some of the most prominent players in the autotransfusion systems market are Fresenius, Atrium Medical Corporation, Haemonetics Corporation, Teleflex Inc, Sarstedt, Inc., and Teleflex Incorporated. Despite the size of the market, there are many players operating in the industry. The report includes independent predictions and quantitative and qualitative analyses of the industry.

The Ecomed system is a unique sterile collection device. The system does not require specialised resources to collect blood. It is easy to set up and use and includes a reusable hard shell canister and a 1.8L soft sterile liner. The device is easy to use and enables the surgeon to suck out blood during surgery and collect blood for reserve. In addition, the system also allows the physician to prescribe anticoagulant medications for the patient.

The US autotransfusion systems market is led by the US and Canada. The majority of these devices are used for cardiac surgery. According to the Texas Heart Institute, thousands of heart surgeries are performed daily. By utilizing autotransfusion systems, the Texas Heart Institute can save hundreds of lives a year. There are numerous other countries that are developing their own autotransfusion devices. They are used for a variety of applications. Its emergence in the US market is largely driven by the increasing prevalence of cardiovascular diseases.

In addition to these two types, the CATSmart autotransfusion system is a revolutionary filtration-based autotransfusion system. It is capable of washing platelets and red blood cells. A study conducted with human whole blood hypothesized that the device will salvage platelets and hematocrits. The SAME is one of the most advanced continuous autotransfusion devices on the market. The CATSmart has a self-start feature, which means it will automatically fill up the holding bag at a rate of 600 ml/min.

The autotransfusion systems market is expected to reach USD 266.7 million in 2019. Compared to a decade ago, the market is anticipated to double in size by 2027. The autotransfusion devices are widely used in surgeries and reduce the risk of infection associated with allogeneic blood transfusions. In the U.S., the demand for these systems is growing due to the high prevalence of heart disorders and robust healthcare reforms.

The autotransfusion market is highly consolidated, with three major players dominating the market in 2019. LivaNova, Haemonetics Corporation, and Fresenius SE & Co. KGaA are among the top three companies in the autotransfusion devices market. They are committed to providing quality products, implementing innovative solutions, and supporting patient blood management. Its XTRA-ATS system has helped reduce the risk of transfusions and shorten hospital stays in over a million patients.